Segan, Louise and Ho Ho, William Wing and Crowley, Rose and William, Jeremy and Cho, Kenneth and Prabh, Sandeep and Chieng, David and Sugumar, Hariharan and Voskoboinik, Aleksandr and Ling, Liang-Han and Kalman, Jonathan M. and Abrams, Dominic and Fatkin, Diane and Takeuchi, Fumihiko and Kistler, Peter M. (2025) Combining polygenic and clinical risk scores in atrial fibrillation risk prediction: Implications for population screening. Heart Rhythm, 22 (8). pp.1906-1914. ISSN 15475271
Full text not available from this repository.Abstract
BACKGROUND: Atrial fibrillation (AF) development is determined by clinical risk factors and genetic predisposition. Few studies have explored whether incorporating polygenic risk scores (PRS) improves clinical-risk prediction beyond existing models. OBJECTIVES: We evaluated the interaction between AF-PRS and the hypertension, age, raised body mass index, male sex, sleep apnea, and smoking-AF (HARMS(2)-AF) and Cohorts for Heart and Aging Research in Genetic Epidemiology for AF (CHARGE-AF) clinical-risk scores on incident AF risk among the United Kingdom Biobank. METHODS: AF-PRS was examined in those with and without incident AF based on International Classification of Diseases, Tenth Revision coding and divided into tertiles defined as low, intermediate, and high-risk categories. Regression analysis examined the impact of AF-PRS combined with the HARMS(2)-AF and CHARGE-AF risk scores and AF risk. RESULTS: Among 285,734 participants with available whole genome sequencing data (52% women, age 57 years [50-63], 84.6% Caucasian), AF incidence was 6.6% with a median time to AF 8.5 (5.0-11.2) over a median 12.9 years follow-up. High AF-PRS tertile was independently associated with incident AF risk, after adjustment for clinical-risk factors (hazard ratio 2.75, 95% confidence interval 2.62-2.89, P<.001). AF-PRS enhanced AF risk prediction when combined with the HARMS(2)-AF risk model area under curve (AUC) 0.828 improved to 0.839 with the addition of AF-PRS (DeLong P<.001) with overall net reclassification index of 13.5% (12.8%-14.1%), and the CHARGE-AF risk model (AUC 0.808 improved to 0.828 with the addition of AF-PRS (DeLong P<.001) with overall net reclassification index of 7.3% (6.7%-7.9%). CONCLUSIONS: Combining genetic and clinical risk using the HARMS(2)-AF and CHARGE-AF risk scores significantly improved AF risk prediction. Incorporating polygenic to clinical-risk scores may enhance population screening and promote targeted interventions to reduce the incidence of AF.
| Item Type: | Article |
|---|---|
| Subjects: | R Medicine > R Medicine (General) |
| Depositing User: | Repository Administrator |
| Date Deposited: | 04 Dec 2025 04:33 |
| Last Modified: | 04 Dec 2025 04:33 |
| URI: | http://eprints.victorchang.edu.au/id/eprint/1766 |
Actions (login required)
 |
View Item |